Articles/Media | My Site

top of page

Selected Articles

Mental Health Disparities/ Trauma

A call for action on overdose among LGBTQ people in North America. Moazen-Zadeh E, et al. Lancet Psychiatry. 2019;6(9):725-726. doi:10.1016/S2215-0366(19)30279-2

Depressive Symptoms Predict Major Depressive Disorder after 15 Years among Whites but Not Blacks. Moazen-Zadeh E, Assari S. Front Public Health. 2016;4:13. Published 2016 Feb 17. doi:10.3389/fpubh.2016.00013

Increased blood pressures in veterans with post traumatic stress disorder. Moazen-Zadeh E, et al. Int J Psychiatry Med. 2016;51(6):576-586. doi:10.1177/0091217417696734

Cannabinoids

Pharmacokinetics of Cannabidiol: A Systematic Review and Meta-Regression Analysis. Moazen-Zadeh E, et al. Cannabis Cannabinoid Res. 2024;9(4):939-966. doi:10.1089/can.2023.0025

Bipolar Disorder

Early intervention for people at high risk of developing bipolar disorder: a systematic review of clinical trials. Saraf G, Moazen-Zadeh E, et al. Lancet Psychiatry. 2021;8(1):64-75. doi:10.1016/S2215-0366(20)30188-7

Addictions

Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials. Moazen-Zadeh E, et al. Am J Drug Alcohol Abuse. 2021;47(3):280-304. doi:10.1080/00952990.2021.1887202

Schizophrenia

More ACTIONS needed to reach a consensus on adjunctive antidepressant therapy for negative symptoms of schizophrenia. Akhondzadeh S, Moazen-Zadeh E. Evid Based Ment Health. 2017;20(1):e3. doi:10.1136/eb-2016-102500

Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial. Moazen-Zadeh E, et al. J Psychopharmacol. 2020;34(5):506-513. doi:10.1177/0269881120909416

bottom of page